Chemotherapy is often given as an IV infusion over hours. That means large volumes of fluid mixed with the drug. The large volume parenteral market research shows that chemotherapy is the fastest‑growing application segment, with a CAGR above 6%. Why? Because cancer rates are rising, and more patients are receiving IV chemo.
What's the challenge? Chemo is toxic — spills can harm nurses and patients. That's why closed system transfer devices (CSTDs) are becoming standard. The large volume parenteral market trends highlight that the fastest‑growing end‑user segment is home healthcare, as patients receive IV antibiotics and hydration at home, avoiding hospital stays.
What's new? Pre‑mixed chemo bags that are ready to hang, reducing preparation time and exposure risk. Also, elastomeric pumps that patients can wear at home, delivering chemo continuously over days.
The bottom line: if you're a cancer patient, ask about home infusion options. It could mean fewer hospital visits and more time at home.
